Touch Screen Usage Time In Relation To Visual Motor Integration and Quality of Life In Preschoolers

NCT ID: NCT04524923

Last Updated: 2021-06-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

97 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-09-01

Study Completion Date

2021-02-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Recent literatures are associating digital technology extensive and addictive use with physical, psychosocial and cognitive inverse consequences. This research focuses more on number of touch screen devices; age started using devices and usage time in relation to cognitive function in preschoolers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A hundred typically developing preschool children of both genders with age ranges from three to five years will be included in this study. Visual motor integration, quality of life and cognitive function were assessed by the Peabody Developmental Motor Scale, the Pediatric Quality of Life Inventory™ and the Pediatric Quality of Life Inventory™ cognitive functioning scale respectively

Sample size To avoid type II error, sample size calculation was based on data from a pilot study on correlation between touch screen usage time and visual motor integration. Using G\*POWER statistica software (version 3.1.9.2; Franz Faul, Universitat Kiel, Germany) \[Correlational study, α=0.05, β=0.2, and medium effect size = 0.3\] revealed that the appropriate sample size for this study was N=84 Therefore, one-hundred children were recruited for possible dropouts during assessment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Child Development

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

cohort group

Ninety-seven typically developing preschool children of both genders with age ranges from three to five years will be included in this study. Visual motor integration, quality of life and cognitive function were assessed by the Peabody Developmental Motor Scale, the Pediatric Quality of Life Inventory™ and the Pediatric Quality of Life Inventory™ cognitive functioning scale respectively

visual motor integration

Intervention Type OTHER

investigate the relation between touch screen usage and visual motor integration in preschoolers

Quality of life assessment

Intervention Type OTHER

investigate the relation between touch screen usage and Quality of life assessment in preschoolers

Cognitive Functioning

Intervention Type OTHER

investigate the relation between touch screen usage and Cognitive Functioning assessment in preschoolers

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

visual motor integration

investigate the relation between touch screen usage and visual motor integration in preschoolers

Intervention Type OTHER

Quality of life assessment

investigate the relation between touch screen usage and Quality of life assessment in preschoolers

Intervention Type OTHER

Cognitive Functioning

investigate the relation between touch screen usage and Cognitive Functioning assessment in preschoolers

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Children were enrolled in this study according to the following criteria:

* Age ranges from three to five years.
* Both genders were included.

Exclusion Criteria

Children were excluded from the study if they had any of the following criteria:

* Diagnosed with attention deficit/hyperactivity disorder (ADD/ADHD) or developmental co-ordination disorder (DCD).
* Preterm children; children with major physical disabilities, genetic disorders; prenatal exposure to alcohol; children with a history of head trauma and infections.
* Diagnosed with psychiatric conditions such as autism and depression.
* Diagnosed with significant behavioral disorders
* Diagnosed with fine motor problems.
* Significant auditory or visual deficits.
Minimum Eligible Age

3 Years

Maximum Eligible Age

5 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Amira M Abd-elmonem, PHD

principle investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Amira M El-tohamy, Phd

Role: STUDY_CHAIR

Cairo University

Amira M Mahmoud

Role: STUDY_DIRECTOR

Cairo University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

faculty of physical therapy, Cairo university

Giza, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

child development

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.